Effectiveness of Yoga and Combined Exercise in Rheumatoid Arthritis

Effectiveness of Yoga and Combined Exercise in Female With Rheumatoid Arthritis: Randomized Controlled Trial

This study aims to elucidate the potential benefits of exercise for individuals with rheumatoid arthritis. The findings are expected to contribute to the development of novel and effective therapeutic approaches, ultimately leading to an improved quality of life for patients. For both patients and healthcare professionals, a clearer understanding of exercise's role in rheumatoid arthritis management will serve as a crucial guide in formulating individualized treatment plans. The results of our study will provide valuable insights to aid in developing strategies aimed at enhancing the physical and mental well-being of individuals afflicted with rheumatoid arthritis.

Rheumatoid arthritis (RA) is a chronic inflammatory disease that significantly impacts daily life by causing pain, swelling, and restricted movement in the joints. This study aimed to investigate the effects of yoga and combined exercise methods on the symptoms of RA in individuals with the condition, comparing them to a control group that did not engage in exercise. Participants were comprehensively evaluated at baseline, week 8, and week 20 for key variables such as pain level, balance, joint mobility, depression level, fatigue level, and quality of life. This research seeks to reveal the potential benefits of exercise in RA management, thereby contributing to the development of effective treatment approaches that improve patients' quality of life. The findings will help both patients and healthcare professionals better understand the role of exercise in RA treatment, serving as a crucial guide for creating individualized treatment plans. The results are expected to offer valuable insights for developing strategies to enhance the physical and mental health of individuals with RA.

Inclusion Criteria:

• diagnosis of RA for at least six months according to the ACR criteria
• aged between 18-65 years,
• under stabil medications at least four weeks
• the disease activity score 28 (DAS 28) <2.6 (Remission period) of each patient at least three months
• ability to provide written informed consent.

Exclusion Criteria:

• had pain that prevents general mobility,
• had neurologic, cardiologic (arrhythmias, myocardial infarction, uncontrolled metabolic disease,
• known electrolyte abnormalities,
• systolic BP > 200 mm Hg or diastolic BP > 115 mm Hg)
• respiratory pathology,
• pregnancy
• had malignancy